Bellicum Pharmaceuticals to Present Updated Results for BPX-601 at the 2019 ASCO Annual Meeting

World News: . []

HOUSTON May 15 2019 GLOBE NEWSWIRE -- LINK  Pharmaceuticals Inc a leader in developing novel controllable cellular immunotherapies for LINK  and orphan inherited blood LINK  today announced that its abstract for LINK  has be en acce...

More news and information about Bellicum Pharmaceuticals, Inc.

Published By:

Globe Newswire: 21:05 GMT Wednesday 15th May 2019

Published: .

Search for other references to "bellicum" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us